Chong Lu

571 total citations
45 papers, 382 citations indexed

About

Chong Lu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Chong Lu has authored 45 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 19 papers in Cancer Research and 9 papers in Immunology. Recurrent topics in Chong Lu's work include MicroRNA in disease regulation (17 papers), Cancer-related molecular mechanisms research (13 papers) and Circular RNAs in diseases (11 papers). Chong Lu is often cited by papers focused on MicroRNA in disease regulation (17 papers), Cancer-related molecular mechanisms research (13 papers) and Circular RNAs in diseases (11 papers). Chong Lu collaborates with scholars based in China, Hong Kong and Australia. Chong Lu's co-authors include Yongqing Lai, Guiling Li, Meng Zhang, Xiaojun Xu, Pyone Myat Thu, Jing Peng, Zu‐Guo Zheng, Hui‐Jun Li, Zuhu Yu and Yaping Zhou and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Biochemical Pharmacology.

In The Last Decade

Chong Lu

42 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chong Lu China	11	190	106	75	61	57	45	382
Zifan Zeng China	12	189 1.0×	66 0.6×	59 0.8×	44 0.7×	37 0.6×	25	362
Jinghui Zheng China	9	230 1.2×	130 1.2×	95 1.3×	66 1.1×	32 0.6×	39	449
Man Shang China	10	230 1.2×	103 1.0×	45 0.6×	79 1.3×	28 0.5×	20	371
Wenyi Jiang China	10	140 0.7×	60 0.6×	104 1.4×	145 2.4×	31 0.5×	13	355
Shumei Ma China	14	232 1.2×	122 1.2×	47 0.6×	48 0.8×	24 0.4×	40	432
Xiaoming Lin China	11	312 1.6×	181 1.7×	42 0.6×	39 0.6×	38 0.7×	35	453
Yuanyi Wei China	12	196 1.0×	68 0.6×	76 1.0×	30 0.5×	28 0.5×	29	349
Xin Fan China	12	183 1.0×	80 0.8×	91 1.2×	85 1.4×	49 0.9×	31	395
Yanqing Jiang China	10	245 1.3×	64 0.6×	105 1.4×	48 0.8×	64 1.1×	16	454
Juanjuan Che China	13	273 1.4×	136 1.3×	149 2.0×	30 0.5×	63 1.1×	20	512

Countries citing papers authored by Chong Lu

Since Specialization

Citations

This map shows the geographic impact of Chong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong Lu more than expected).

Fields of papers citing papers by Chong Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong Lu. The network helps show where Chong Lu may publish in the future.

Co-authorship network of co-authors of Chong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Chong Lu. A scholar is included among the top collaborators of Chong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chong Lu. Chong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Hui, et al.. (2025). SNX10 Is Involved in Ovarian Cancer Cell Metastasis by Repolarizing Tumor-Associated Macrophages Through mTOR1/Lysosomes Pathway. Biomedicines. 13(5). 1021–1021. 1 indexed citations

Zeng, Yingying, Hui Cai, Chong Lu, et al.. (2025). Transcriptome-Wide Analysis of N6-Methyladenosine-Modified Long Noncoding RNAs in Particulate Matter-Induced Lung Injury. Toxics. 13(2). 98–98. 1 indexed citations

Sun, Chen, Chong Lu, Wenkang Chen, et al.. (2025). Serum mature microRNA panel: A novel approach for primary prostate cancer diagnosis. Clinica Chimica Acta. 569. 120150–120150.

Peng, Jing, et al.. (2024). Identification of Siglec-10 as a new dendritic cell checkpoint for cervical cancer immunotherapy. Journal for ImmunoTherapy of Cancer. 12(8). e009404–e009404. 7 indexed citations

Lu, Chong, et al.. (2024). miRNA-27b-3p, let-7f-5p and miRNA-142-5p can be Used in a Novel Serum Diagnostic Panel for Clear Cell Renal Cell Carcinoma. Frontiers in Bioscience-Landmark. 29(5). 186–186. 1 indexed citations

Zeng, Yingying, Chong Lu, Hui Cai, et al.. (2024). Edaravone alleviated allergic airway inflammation by inhibiting oxidative stress and endoplasmic reticulum stress. European Journal of Pharmacology. 966. 176317–176317. 5 indexed citations

Sun, Chen, Chong Lu, Wenkang Chen, et al.. (2024). The value of a panel of circulating microRNAs in screening prostate cancer. Translational Cancer Research. 13(2). 686–698. 3 indexed citations

Peng, Jing, et al.. (2024). Combining cisplatin with Pinellia pedatisecta Schott lipid-soluble extract induces tumor immunogenic cell death in cervical cancer. Phytomedicine. 128. 155504–155504. 5 indexed citations

Zhao, Yihong, et al.. (2023). Study on identification of a three-microRNA panel in serum for diagnosing neonatal early onset sepsis. The Journal of Maternal-Fetal & Neonatal Medicine. 36(2). 2280527–2280527. 2 indexed citations

10.

Yu, Zuhu, et al.. (2023). A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs. BMC Genomics. 24(1). 162–162. 1 indexed citations

11.

Chen, Wenkang, Chong Lu, Xuan Chen, et al.. (2023). A four-microRNA panel in serum may serve as potential biomarker for renal cell carcinoma diagnosis. Frontiers in Oncology. 12. 1076303–1076303. 10 indexed citations

12.

Lu, Chong, et al.. (2023). Chronic Stress Blocks the Endometriosis Immune Response by Metabolic Reprogramming. International Journal of Molecular Sciences. 25(1). 29–29. 5 indexed citations

13.

Yu, Zuhu, Chong Lu, & Yongqing Lai. (2023). A serum miRNAs signature for early diagnosis of bladder cancer. Annals of Medicine. 55(1). 736–745. 18 indexed citations

14.

Lu, Chong, et al.. (2022). A Four-MicroRNA Panel in Serum as a Potential Biomarker for Screening Renal Cell Carcinoma. Frontiers in Genetics. 13. 897827–897827. 8 indexed citations

15.

Xu, Jing, Ké Li, Jing Wang, et al.. (2022). An effective AKT inhibitor-PARP inhibitor combination therapy for recurrent ovarian cancer. Cancer Chemotherapy and Pharmacology. 89(5). 683–695. 10 indexed citations

16.

Lu, Chong, Yan Cao, Li Liu, et al.. (2021). MALAT1 Regulated mTOR-Mediated Tau Hyperphosphorylation by Acting as a ceRNA of miR144 in Hippocampus Cells Exposed to High Glucose. Clinical Interventions in Aging. Volume 16. 1185–1191. 9 indexed citations

17.

Peng, Jing, Fangfang Zhong, Mingxing Zhang, et al.. (2021). Clinical analysis of uterine intravenous leiomyomatosis: A retrospective study of 260 cases. Journal of obstetrics and gynaecology research. 47(12). 4357–4364. 13 indexed citations

18.

Fu, Yi‐Peng, Meng Zhang, Chong Lu, et al.. (2020). An Innovative Immune Score‐Based Prognostic Nomogram for Patients with Cervical Cancer. BioMed Research International. 2020(1). 8882576–8882576. 3 indexed citations

19.

Li, Xinyu, Xiaorong Zhan, Chong Lu, Xiao-Min Liu, & Xiaochen Wang. (2010). Mechanisms of hepatocyte growth factor-mediated signaling in differentiation of pancreatic ductal epithelial cells into insulin-producing cells. Biochemical and Biophysical Research Communications. 398(3). 389–394. 10 indexed citations

20.

Wang, Xiaonan, et al.. (2010). Effects of Celastrol on growth inhibition of U937 leukemia cells through the regulation of the Notch1/NF-kappa B signaling pathway in vitro. Chinese Journal of Cancer. 29(4). 385–390. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact